APRIL levels are associated with disease activity in human chronic graft-versus-host disease

Haematologica. 2016 Jul;101(7):e312-5. doi: 10.3324/haematol.2016.145409. Epub 2016 Mar 18.

¹ INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
² INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité
³ University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
⁴ University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
⁵ University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris Therapeutic Apheresis Unit, Saint-Louis Hospital, Paris.
⁶ University Paris Diderot, Sorbonne Paris Cité Immunobiology Department, Saint-Louis Hospital, Paris.
⁷ University Paris Diderot, Sorbonne Paris Cité Pneumology Department, Saint-Louis Hospital, Paris.
⁸ University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris INSERM and UMRS1160, France [email protected].

No abstract available

Keywords: APRIL; B cell homeostasis; BAFF; autoantibody; chronic graft-versus-host disease.

Publication types